Nyt News Service News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nyt news service. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nyt News Service Today - Breaking & Trending Today

bankruptcy: Lawyers land $700 million bounty from crypto collapse

Lawyers, accountants, consultants, cryptocurrency analysts and other professionals have racked up more than $700 million in fees since last year from the bankruptcies of five major crypto firms, including the digital currency exchange FTX, according to a New York Times analysis of court records. That sum is likely to grow significantly as the cases unfold over the coming months. ....

New York , United States , Lynn Lopucki , Kirkland Ellis , Johnj Ray , Tiffany Fong , Andrew Dietderich , A Kirkland Ellis , Joseph Doherty , Katherine Stadler , Daniel Frishberg , Alvarez Marsal , Celsius Network , Nyt News Service , New York Times , Sullivan Cromwell , Fruit Of The Loom , Voyager Digital , Crypto Collapse ,

consumer prices: China's economy faces yet another threat: Falling prices

Consumer prices in China, after barely rising for the previous several months, fell in July for the first time in more than two years, the country s National Bureau of Statistics announced on Wednesday. For 10 straight months, the wholesale prices generally paid by businesses to factories and other producers have been down from a year earlier. Real estate prices are tumbling. ....

Wang Dan , Hong Kong , United States , Fu Linghui , Adams Posen , Eswar Prasad , Foreign Affairs , Peterson Institute For International Economics , National Bureau Of Statistics , Hang Seng Bank China , International Monetary Fund , Nyt News Service , Beike Research Institute , Cornell University , National Bureau , International Monetary , Hang Seng Bank , Andrew Collier , Orient Capital Research , Peterson Institute , International Economics , Consumer Prices , China Deflation , Money Supply , Xi Jinping ,

How a drugmaker profited by slow-walking a promising HIV therapy

Today, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for HIV treatment and prevention, according to IQVIA, an industry data provider. One widely used product, Descovy, has a sticker price of $26,000 annually. Generic versions of its predecessor, Truvada, whose patents have expired, now cost less than $400 a year. ....

Slovak Republic , United States , Norbert Bischofberger , James Krellenstein , David Swisher , John Milligan , Julie Cunningham , Christopher Morten , Deborah Telman , Columbia University , Gilead Sciences , Us National Institutes Of Health , Drug Administration , World Health Organization , Nyt News Service , Central Florida , Hiv Therapy ,